Scinai Immunotherapeutics Ltd.
SCNI
$0.51
-$0.03-5.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.09M | -2.09M | -2.07M | -2.07M | -2.23M |
| Total Depreciation and Amortization | 358.50K | 358.50K | 352.00K | 352.00K | 499.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 194.50K | 194.50K | 151.50K | 151.50K | 180.00K |
| Change in Net Operating Assets | -194.50K | -194.50K | 276.00K | 276.00K | 475.00K |
| Cash from Operations | -1.73M | -1.73M | -1.29M | -1.29M | -1.08M |
| Capital Expenditure | -6.00K | -6.00K | -6.00K | -6.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -6.00K | -6.00K | -6.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.09M | 2.09M | 790.50K | 790.50K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2.00M |
| Cash from Financing | 2.09M | 2.09M | 790.50K | 790.50K | 2.00M |
| Foreign Exchange rate Adjustments | -20.50K | -20.50K | 21.00K | 21.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 340.00K | 340.00K | -482.00K | -482.00K | 926.00K |